Author

Peijia Jiang

Dalhousie UniversityORCID 0000-0002-7221-5911Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:mechanistic / dynamical model· 1 Assay:protein structure· 1

Frequent Co-Authors

Byong Hoon Yoo· 1 shared Kirill V. RoseniD· 1 shared Sandhya ChipurupalliiD· 1 shared Xiaoyang LiuiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Byong Hoon Yoo

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCell Death and DiseasePeer-reviewedFeb 20, 2025

Inactivation of necroptosis-promoting protein MLKL creates a therapeutic vulnerability in colorectal cancer cells.

Peijia Jiang, Sandhya Chipurupalli, Byong Hoon Yoo…·Kirill V. Rosen

This study shows that inhibiting MLKL in colorectal cancer cells enhances their sensitivity to homoharringtonine, a drug that blocks autophagy, by disrupting VPS37A-dependent autophagy and triggering parthanatos.

11 citations

humanbulk RNA-seq